⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of NKure Therapeutics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
NKure Therapeutics
↗Bengaluru, India
NKure Therapeutics is a Bengaluru-based biotechnology startup dedicated to democratizing access to cancer immunotherapy in India. The company focuses on developing scalable, affordable, off-the-shelf Natural Killer (NK) cell-based therapies to treat various cancers and infectious diseases, aiming to overcome the high costs and limitations associated with traditional autologous cell therapies.
Founded in 2022 by industry veterans, the company operates out of the Centre for Cellular and Molecular Platforms (C-CAMP). NKure is actively building a pipeline of allogeneic NK cell therapies through both in-house development and strategic international collaborations, including partnerships to license specialized CAR and NK cell technologies.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2022
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$2.2M+
Investors:Endiya Partners, Featherlite Office Systems, Jacesa Investment, Kotak Alternate Assets Managers, Centre for Cellular and Molecular Platforms (C-CAMP)
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical
Modalities:Cell therapy, Natural Killer (NK) cells
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:CRISPR Therapeutics (Co-development of CTX112™), Medigen Biotechnology Corp (Licensing of Magicell®-NK technology), Cytecare Cancer Hospital (Clinical trial collaboration)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Dr. Mahendra Rao - Founder
Lalit Pai - CEO
Dr. Renjitha Gopurappilly - Chief Scientific Officer
Scientific Founders:Dr. Mahendra Rao
LINKS
Website:nkure.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with NKure Therapeutics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.